GlassScriptPhysician profile
Sam Shumway
NPI 1134468267
$1,086.49
in general payments reported to CMS, 2019-2025
19 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $514 · 2023: $146 · 2024: $87.54 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $132.94 | 2022-2024 | Freestyle Libre 3 |
| Redhill Biopharma INC. | $119.77 | 2021 | |
| Abbvie INC. | $107.13 | 2022 | |
| Sanofi Pasteur INC. | $83.67 | 2021-2025 | |
| Pfizer INC. | $82.47 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.41 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.78 | 2021-2023 | Jardiance |
| Lucid Diagnostics INC. | $71.40 | 2022-2023 | |
| Novo Nordisk INC | $56.96 | 2022-2023 | Ozempic |
| Cranial Technologies, INC | $47.73 | 2022-2024 | Doc Band |
| Medtronic, INC. | $45.68 | 2023-2025 | Resolute Onyx, Micra |
| Lilly USA, LLC | $45.60 | 2021-2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $41.17 | 2022-2023 | Superion Indirect Decompression System |
| Novartis Pharmaceuticals Corporation | $24.27 | 2022 | |
| Phadia US INC. | $23.06 | 2023 | Immunocap |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.57 | 2022 | |
| Merck Sharp & Dohme LLC | $13.83 | 2023 | Gardasil 9, Vaqta, Vaxneuvance |
| Abiomed | $13.75 | 2024 | Impella |
| Arbor Pharmaceuticals, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Shumway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.